Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 1,551–1,560 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 1551
- Medicine slug
- toremifene
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 3
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
4 hours
- Numeric value
- 4
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cab8dd1-3a10-48e6-86ce-0e5275ed49e5 (opens source in a new tab)
Toremifene label
Version not recorded · Effective date not recorded
Elimination - The plasma concentration time profile of toremifene declines biexponentially after absorption with a mean distribution half-life of about 4 hours and an elimination half-life of about 5 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e897546b-4136-4cb5-a262-d94cf3fa3298 (opens source in a new tab)
Toremifene label
Version not recorded · Effective date not recorded
Elimination – The plasma concentration time profile of toremifene declines biexponentially after absorption with a mean distribution half-life of about 4 hours and an elimination half-life of about 5 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dbde10d5-c689-428f-841d-b34aa5addf2d (opens source in a new tab)
Toremifene label
Version not recorded · Effective date not recorded
Elimination – The plasma concentration time profile of toremifene declines biexponentially after absorption with a mean distribution half-life of about 4 hours and an elimination half-life of about 5 days.
Projected row 1552
- Medicine slug
- toremifene
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 3
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
3 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cab8dd1-3a10-48e6-86ce-0e5275ed49e5 (opens source in a new tab)
Toremifene label
Version not recorded · Effective date not recorded
Peak plasma concentrations are obtained within 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e897546b-4136-4cb5-a262-d94cf3fa3298 (opens source in a new tab)
Toremifene label
Version not recorded · Effective date not recorded
Peak plasma concentrations are obtained within 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dbde10d5-c689-428f-841d-b34aa5addf2d (opens source in a new tab)
Toremifene label
Version not recorded · Effective date not recorded
Peak plasma concentrations are obtained within 3 hours.
Projected row 1553
- Medicine slug
- toremifene
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 3
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
580 L
- Numeric value
- 580
- Unit
- L
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cab8dd1-3a10-48e6-86ce-0e5275ed49e5 (opens source in a new tab)
Toremifene label
Version not recorded · Effective date not recorded
Distribution - Toremifene has an apparent volume of distribution of 580 L and binds extensively (>99.5%) to serum proteins, mainly albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e897546b-4136-4cb5-a262-d94cf3fa3298 (opens source in a new tab)
Toremifene label
Version not recorded · Effective date not recorded
Distribution – Toremifene has an apparent volume of distribution of 580 L and binds extensively (>99.5%) to serum proteins, mainly albumin.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dbde10d5-c689-428f-841d-b34aa5addf2d (opens source in a new tab)
Toremifene label
Version not recorded · Effective date not recorded
Distribution – Toremifene has an apparent volume of distribution of 580 L and binds extensively (>99.5%) to serum proteins, mainly albumin.
Projected row 1554
- Medicine slug
- torsemide
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 32
- Source count
- 32
- Agreement rate
- 1
- Recorded readings
80%
- Numeric value
- 80
- Unit
- %
- Source records
- 32
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 32 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16dfba29-4c26-45e7-ac7d-b2ec2058e2bb (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:234ff9d7-a02e-417f-a1f9-94038783cc77 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e9c6ee1-c49f-4f59-9391-8a9b57becb02 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c755d94-b846-4336-a968-aa1b92dc0ac0 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da8f2bf5-741c-45f6-b873-31a9fda2f880 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6055317-8826-df85-e053-2a95a90a5378 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55e88727-864e-4313-860c-31a6ca45168f (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e58a7d1c-6584-44c3-98ce-a3e9b64e9c82 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2411e6f8-4fc3-f986-e063-6294a90a055a (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91d45625-5ba6-b50f-e053-2a95a90ac314 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Adverse drug interactions have not been observed, and special dosage adjustment has not been necessary. 12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:26a3af16-39fc-482d-8a8e-9473af4b0e3f (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a95cbdb-0601-47a5-9b3a-0c3b0629ceb9 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a3d68763-95e0-4ad6-89c2-c4b1c0b43948 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Adverse drug interactions have not been observed, and special dosage adjustment has not been necessary. 12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:159e8c90-ebc6-0991-e063-6394a90aae19 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03fbbb85-4e0f-4f3b-b4b0-87f84cb33d47 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44f2f06d-7bc4-5239-e063-6394a90aac5e (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aaabbaca-ba6f-42d5-980d-71135c7c80ea (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c8f1c0b-8a44-4ca0-b2cf-3c591f8878fd (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b869bc45-1ebb-42fb-82c5-603f09835790 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ed913ba-f0c0-4ba5-9440-73c4374f4226 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1439b9c-c01c-a6d4-594b-d92b8e0af26e (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Adverse drug interactions have not been observed, and special dosage adjustment has not been necessary. 12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with little intersubject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99b537f3-1fbf-48b7-ac3e-0a43e6aab313 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f24151c8-02cd-4b07-a7fd-796903210aba (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05c8a6ee-9517-453f-8dd6-7e5ca83c5a68 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e707eda7-4bde-4944-ae19-1b4fa35b6a3c (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fde1d1be-0faa-440a-9039-bdb103288c76 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:201e892d-d963-4c6a-b35b-c5780b01f659 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09305350-e317-419c-96f5-aa8fbeb4044d (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13d851b6-3355-4541-93e8-73cdaf0f13d1 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b3cfce4-61fc-42ba-9ea7-51f81ea014f7 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0d4a4ef9-0944-452c-b014-bd822bfb9dd9 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7fc14338-92e4-cf57-a3e8-ef64d8d1026c (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The bioavailability of torsemide tablets is approximately 80%, with small inter-subject variation; the 90% confidence interval is 75% to 89%.
Projected row 1555
- Medicine slug
- torsemide
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 32
- Source count
- 32
- Agreement rate
- 1
- Recorded readings
3.5 hours
- Numeric value
- 3.5
- Unit
- hours
- Source records
- 32
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 32 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16dfba29-4c26-45e7-ac7d-b2ec2058e2bb (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:234ff9d7-a02e-417f-a1f9-94038783cc77 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e9c6ee1-c49f-4f59-9391-8a9b57becb02 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c755d94-b846-4336-a968-aa1b92dc0ac0 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da8f2bf5-741c-45f6-b873-31a9fda2f880 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6055317-8826-df85-e053-2a95a90a5378 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55e88727-864e-4313-860c-31a6ca45168f (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e58a7d1c-6584-44c3-98ce-a3e9b64e9c82 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2411e6f8-4fc3-f986-e063-6294a90a055a (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91d45625-5ba6-b50f-e053-2a95a90ac314 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:26a3af16-39fc-482d-8a8e-9473af4b0e3f (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a95cbdb-0601-47a5-9b3a-0c3b0629ceb9 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a3d68763-95e0-4ad6-89c2-c4b1c0b43948 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:159e8c90-ebc6-0991-e063-6394a90aae19 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03fbbb85-4e0f-4f3b-b4b0-87f84cb33d47 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44f2f06d-7bc4-5239-e063-6394a90aac5e (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aaabbaca-ba6f-42d5-980d-71135c7c80ea (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c8f1c0b-8a44-4ca0-b2cf-3c591f8878fd (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b869bc45-1ebb-42fb-82c5-603f09835790 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ed913ba-f0c0-4ba5-9440-73c4374f4226 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1439b9c-c01c-a6d4-594b-d92b8e0af26e (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99b537f3-1fbf-48b7-ac3e-0a43e6aab313 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f24151c8-02cd-4b07-a7fd-796903210aba (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05c8a6ee-9517-453f-8dd6-7e5ca83c5a68 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e707eda7-4bde-4944-ae19-1b4fa35b6a3c (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fde1d1be-0faa-440a-9039-bdb103288c76 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:201e892d-d963-4c6a-b35b-c5780b01f659 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09305350-e317-419c-96f5-aa8fbeb4044d (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13d851b6-3355-4541-93e8-73cdaf0f13d1 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b3cfce4-61fc-42ba-9ea7-51f81ea014f7 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0d4a4ef9-0944-452c-b014-bd822bfb9dd9 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7fc14338-92e4-cf57-a3e8-ef64d8d1026c (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Elimination In normal subjects the elimination half-life of torsemide is approximately 3.5 hours.
Projected row 1556
- Medicine slug
- torsemide
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 32
- Source count
- 32
- Agreement rate
- 1
- Recorded readings
99%
- Numeric value
- 99
- Unit
- %
- Source records
- 32
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 32 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16dfba29-4c26-45e7-ac7d-b2ec2058e2bb (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:234ff9d7-a02e-417f-a1f9-94038783cc77 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e9c6ee1-c49f-4f59-9391-8a9b57becb02 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c755d94-b846-4336-a968-aa1b92dc0ac0 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da8f2bf5-741c-45f6-b873-31a9fda2f880 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6055317-8826-df85-e053-2a95a90a5378 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55e88727-864e-4313-860c-31a6ca45168f (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e58a7d1c-6584-44c3-98ce-a3e9b64e9c82 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2411e6f8-4fc3-f986-e063-6294a90a055a (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91d45625-5ba6-b50f-e053-2a95a90ac314 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:26a3af16-39fc-482d-8a8e-9473af4b0e3f (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a95cbdb-0601-47a5-9b3a-0c3b0629ceb9 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a3d68763-95e0-4ad6-89c2-c4b1c0b43948 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (greater than 99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:159e8c90-ebc6-0991-e063-6394a90aae19 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03fbbb85-4e0f-4f3b-b4b0-87f84cb33d47 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44f2f06d-7bc4-5239-e063-6394a90aac5e (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aaabbaca-ba6f-42d5-980d-71135c7c80ea (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c8f1c0b-8a44-4ca0-b2cf-3c591f8878fd (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b869bc45-1ebb-42fb-82c5-603f09835790 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ed913ba-f0c0-4ba5-9440-73c4374f4226 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1439b9c-c01c-a6d4-594b-d92b8e0af26e (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Because torsemide is extensively bound to plasma protein (>99%), very little enters tubular urine via glomerular filtration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99b537f3-1fbf-48b7-ac3e-0a43e6aab313 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f24151c8-02cd-4b07-a7fd-796903210aba (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05c8a6ee-9517-453f-8dd6-7e5ca83c5a68 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e707eda7-4bde-4944-ae19-1b4fa35b6a3c (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fde1d1be-0faa-440a-9039-bdb103288c76 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:201e892d-d963-4c6a-b35b-c5780b01f659 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09305350-e317-419c-96f5-aa8fbeb4044d (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13d851b6-3355-4541-93e8-73cdaf0f13d1 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b3cfce4-61fc-42ba-9ea7-51f81ea014f7 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0d4a4ef9-0944-452c-b014-bd822bfb9dd9 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7fc14338-92e4-cf57-a3e8-ef64d8d1026c (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Torsemide is extensively bound to plasma protein (>99%).
Projected row 1557
- Medicine slug
- torsemide
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 32
- Source count
- 32
- Agreement rate
- 0.96875
- Recorded readings
12 to 15 liters
- Numeric value
- 12
- Unit
- L
- Source records
- 31
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 31 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16dfba29-4c26-45e7-ac7d-b2ec2058e2bb (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:234ff9d7-a02e-417f-a1f9-94038783cc77 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e9c6ee1-c49f-4f59-9391-8a9b57becb02 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c755d94-b846-4336-a968-aa1b92dc0ac0 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da8f2bf5-741c-45f6-b873-31a9fda2f880 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6055317-8826-df85-e053-2a95a90a5378 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55e88727-864e-4313-860c-31a6ca45168f (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e58a7d1c-6584-44c3-98ce-a3e9b64e9c82 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2411e6f8-4fc3-f986-e063-6294a90a055a (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91d45625-5ba6-b50f-e053-2a95a90ac314 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:26a3af16-39fc-482d-8a8e-9473af4b0e3f (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a95cbdb-0601-47a5-9b3a-0c3b0629ceb9 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a3d68763-95e0-4ad6-89c2-c4b1c0b43948 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:159e8c90-ebc6-0991-e063-6394a90aae19 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03fbbb85-4e0f-4f3b-b4b0-87f84cb33d47 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44f2f06d-7bc4-5239-e063-6394a90aac5e (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aaabbaca-ba6f-42d5-980d-71135c7c80ea (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c8f1c0b-8a44-4ca0-b2cf-3c591f8878fd (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b869bc45-1ebb-42fb-82c5-603f09835790 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ed913ba-f0c0-4ba5-9440-73c4374f4226 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99b537f3-1fbf-48b7-ac3e-0a43e6aab313 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f24151c8-02cd-4b07-a7fd-796903210aba (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05c8a6ee-9517-453f-8dd6-7e5ca83c5a68 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e707eda7-4bde-4944-ae19-1b4fa35b6a3c (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fde1d1be-0faa-440a-9039-bdb103288c76 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:201e892d-d963-4c6a-b35b-c5780b01f659 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09305350-e317-419c-96f5-aa8fbeb4044d (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13d851b6-3355-4541-93e8-73cdaf0f13d1 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b3cfce4-61fc-42ba-9ea7-51f81ea014f7 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0d4a4ef9-0944-452c-b014-bd822bfb9dd9 (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7fc14338-92e4-cf57-a3e8-ef64d8d1026c (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
12 liters
- Numeric value
- 12
- Unit
- L
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1439b9c-c01c-a6d4-594b-d92b8e0af26e (opens source in a new tab)
Torsemide label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of torsemide is 12 liters to 15 liters in normal adults or in patients with mild to moderate renal failure or congestive heart failure.
Projected row 1558
- Medicine slug
- trabectedin
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
175 hours
- Numeric value
- 175
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1d50f5c-4202-27f3-4798-a9708114ddea (opens source in a new tab)
Trabectedin label
Version not recorded · Effective date not recorded
Elimination The estimated mean (% coefficient of variation) clearance of trabectedin is 31.5 L/hr (50%) and the terminal elimination half-life is approximately 175 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:472bd78e-be17-4b9d-90f4-9482c3aec9ff (opens source in a new tab)
Trabectedin label
Version not recorded · Effective date not recorded
Elimination The estimated mean (% coefficient of variation) clearance of trabectedin is 31.5 L/hr (50%) and the terminal elimination half-life is approximately 175 hours.
Projected row 1559
- Medicine slug
- trabectedin
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 0.5
- Recorded readings
5,000 L
- Numeric value
- 5,000
- Unit
- L
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1d50f5c-4202-27f3-4798-a9708114ddea (opens source in a new tab)
Trabectedin label
Version not recorded · Effective date not recorded
Steady state volume of distribution of trabectedin exceeds 5,000 L.
5000 L
- Numeric value
- 5,000
- Unit
- L
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:472bd78e-be17-4b9d-90f4-9482c3aec9ff (opens source in a new tab)
Trabectedin label
Version not recorded · Effective date not recorded
Steady state volume of distribution of trabectedin exceeds 5000 L.
Projected row 1560
- Medicine slug
- tramadol
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 98
- Source count
- 58
- Agreement rate
- 1
- Recorded readings
75%
- Numeric value
- 75
- Unit
- %
- Source records
- 58
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 58 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2236031d-8596-4c21-8b16-83aa3e4122c1 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f4ea18b0-2cbd-0d42-e053-2995a90a9264 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b5360f8-3e95-a047-e063-6294a90a7315 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18d9e3e4-5892-43b8-b211-3ef3393ad946 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:515baa9a-b226-4bbe-be87-f9befdf1c9e1 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54d74939-301b-e603-e063-6394a90a3b03 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93b12089-3a0f-4b57-abb1-2429cf31995d (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5685c80-c84d-d0a1-e053-2995a90afc54 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61fb5ba7-6896-4ee4-83de-caee69b06a8e (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42de8c3a-0441-5d46-e063-6294a90a2079 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f44c53ec-26ea-d272-e053-2a95a90a5e59 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3135a131-5f2d-3775-e063-6394a90a4322 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b0b95b2-ae4c-42e8-9f2e-bcdaffda62e2 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7e75fd3-18d1-4370-bb63-c9dd8a2c1719 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5babcfcf-331b-5db9-e053-2a91aa0aaf89 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6e275c3-1e16-4a00-b7fd-608ae6cbd515 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f558c59c-cbd4-4b17-9a3d-b014ad09bbb1 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:561f00e5-f69c-4369-ae4d-5eff86c4499f (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67919c2c-2f8a-4bbb-bef5-0cd6c1e63a16 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:855905c7-1481-4b2d-a318-3254ad8ed73c (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af87fc31-07c2-b1f7-e053-2995a90a499f (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e738ced-9cde-e776-e063-6294a90a7e33 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a60bd36-7dcc-49c3-b6de-b263fdaa312c (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:552e5b32-accf-29dd-e063-6294a90a4fcf (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5199132e-745e-46a0-8068-e06d1bca5c61 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50f4b752-20af-4ebf-9408-e78f30d2a3cc (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e90d4ef3-8b90-41b7-bf96-340852e89b5f (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6ebc5864-c222-4400-a9b2-f66fd6fb0da6 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27460cc6-0782-7838-e063-6394a90a19f1 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6104e62-5b2c-41a1-afb3-00dcf267a384 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f0e33bd-65f8-446a-886f-e7e16a142ce5 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5005d9e-91cb-4ff8-bcf2-b5ee70cf4f3f (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:728157e2-d153-4ea0-81eb-36599dc7dfda (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05f8e06b-f3eb-4cb2-aee5-bd0b03884178 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84b12129-cf10-4a3e-889c-990ebabdece6 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3d719560-7449-f970-e063-6294a90a9bd8 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a886d551-6b57-4d9d-87f4-e1366385c7fd (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:007bf37f-0e46-426a-ac8c-be63d4b7414c (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5852b90-e415-47ef-8f73-87266b58e033 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ec4e4e5-a56e-4198-8428-6b770b9bf27d (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bf66203-8b45-475d-9a70-4d7c8bdfe6b3 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bbd6c0d4-110c-4bda-9d9f-89ab7ce4c18e (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f79fda81-f09a-4a08-babc-6bd3bb3ee661 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e79e1fa-3473-f4a7-e063-6294a90a9576 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f4c148f3-845a-61e3-e053-2a95a90a326e (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:552955e6-2bb3-8755-e063-6394a90ab21c (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58b802cb-2443-4f5b-9718-7d54c6d50cb4 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1cd3caee-bf54-7aba-e063-6394a90ad8cb (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a525cf7-2c0c-47c6-aed3-3a395a7120ec (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2f421ab-35ae-7637-e053-2995a90a40e0 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24aea499-c6f1-9200-e063-6394a90a9db6 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a63eadda-cabb-4f2c-86f9-2d8b4a2c88f3 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aea56ff9-94ac-47a8-8f15-8790d538973b (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
199.82 AUC 0-inf (hr*ng/mL) 1658.31 ± 525.97 1721.47 ± 624.72 638.95 ± 207.13 639.26 ± 198.04 t 1/2 (hr) 7.65 ± 1.63 7.61 ± 1.82 7.94 ± 1.65 8.06 ± 2.11 The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d4af58f-17f3-4cbd-870c-098ace954872 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6f6069b-cc75-4b87-afa5-b83001b543e0 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5285f056-c32c-4e7a-bec6-3a726aa23d5a (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9282800-fde7-477a-8b8f-59617ec26f73 (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:674803a0-4cf5-4416-a5e3-c1a1e332cdcd (opens source in a new tab)
Tramadol label
Version not recorded · Effective date not recorded
Absorption The mean absolute bioavailability of a 100 mg oral dose is approximately 75%.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=1550Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.